Literature DB >> 23902785

Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.

Céline M Op den Kamp1, Ramon C Langen, Frank J Snepvangers, Chiel C de Theije, Johanna M Schellekens, Fabian Laugs, Anne-Marie C Dingemans, Annemie M Schols.   

Abstract

BACKGROUND: Experimental models of cancer cachexia have indicated that systemic inflammation induces muscle-protein breakdown and wasting via muscular nuclear transcription factor κB (NF-κB) activation. This process may limit the efficacy of nutritional intervention.
OBJECTIVES: We assessed muscle NF-κB activity and protein turnover signaling in progressive stages of clinical lung cancer cachexia and assessed whether circulating factors can induce muscular NF-κB activity.
DESIGN: Patients with lung cancer precachexia (n = 10) and cachexia (n = 16) were cross-sectionally compared with 22 healthy control subjects. mRNA transcripts of muscle proteolytic (ubiquitin proteasome system and autophagy lysosomal pathway) and myogenic markers and protein expression of PI3K/Akt, myostatin, and autophagy signaling were measured. A multiplex analysis showed the systemic inflammatory status, whereas plasma exposure to stable NF-κB-luciferase-reporter muscle cells revealed NF-κB inducibility.
RESULTS: Compared with healthy control subjects, cachectic patients had reduced (appendicular) muscle mass (-10%), muscle fiber atrophy (-27%), and decreased quadriceps strength (-31%). Subtle alterations in the muscle morphology were also detectable in precachectic patients, without changes in body composition. Despite increased Akt phosphorylation, downstream phosphosubstrates glycogen synthase kinase 3β, mammalian target of rapamycin, and Forkhead box protein were unaltered. The expression of autophagy effectors B cell lymphoma 2/adenovirus E1B 19-kDa protein-interacting protein 3 and microtubule-associated proteins 1A/1B light chain 3B gradually increased from precachectic to cachectic patients, without differences in E3 ubiquitin ligases. Systemic and local inflammation was evident in cachexia and intermediate in precachexia, but the plasma of both patients groups caused ex vivo muscle NF-κB activation.
CONCLUSIONS: In lung cancer, muscular NF-κB activity is induced by factors contained within the circulation. Autophagy may contribute to increased muscle proteolysis in lung cancer cachexia, whereas the absence of downstream changes in phosphosubstrates despite increased Akt phosphorylation suggests impaired anabolic signaling that may require targeted nutritional intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23902785     DOI: 10.3945/ajcn.113.058388

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  60 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

Review 2.  Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model.

Authors:  Karin J C Sanders; Samuel Y Ash; George R Washko; Felix M Mottaghy; Annemie M W J Schols
Journal:  J Appl Physiol (1985)       Date:  2017-07-27

3.  Exercise in ZDF rats does not attenuate weight gain, but prevents hyperglycemia concurrent with modulation of amino acid metabolism and AKT/mTOR activation in skeletal muscle.

Authors:  Olasunkanmi A J Adegoke; Holly E Bates; Michael A Kiraly; Mladen Vranic; Michael C Riddell; Errol B Marliss
Journal:  Eur J Nutr       Date:  2014-08-13       Impact factor: 5.614

4.  Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.

Authors:  Kleiton Augusto Santos Silva; Jiangling Dong; Yanjun Dong; Yanlan Dong; Nestor Schor; David J Tweardy; Liping Zhang; William E Mitch
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

Review 5.  Molecular mechanism of sarcopenia and cachexia: recent research advances.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2017-01-19       Impact factor: 3.657

Review 6.  Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise.

Authors:  Ben D Perry; Marissa K Caldow; Tara C Brennan-Speranza; Melissa Sbaraglia; George Jerums; Andrew Garnham; Chiew Wong; Pazit Levinger; Muhammad Asrar Ul Haq; David L Hare; S Russ Price; Itamar Levinger
Journal:  Exerc Immunol Rev       Date:  2016       Impact factor: 6.308

Review 7.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

8.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

9.  Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death.

Authors:  Xuezhong Gong; Vladimir N Ivanov; Mercy M Davidson; Tom K Hei
Journal:  Arch Toxicol       Date:  2014-06-25       Impact factor: 5.153

Review 10.  Protein anabolic resistance in cancer: does it really exist?

Authors:  Mariëlle P K J Engelen; Barbara S van der Meij; Nicolaas E P Deutz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2016-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.